AIM-100 is primarily used in biochemical and pharmacological research as a selective inhibitor of the protein kinase AKT (also known as PKB). It is employed to study signaling pathways involved in cell growth, survival, and metabolism, particularly in cancer-related studies. Researchers use AIM-100 to probe the role of AKT isoforms in tumor progression and to evaluate potential therapeutic strategies for cancers with hyperactive AKT signaling. Its selectivity makes it a valuable tool for distinguishing AKT-dependent effects from those mediated by related kinases. AIM-100 is not used clinically but serves as an important compound in preclinical research to understand oncogenic signaling and to support the development of targeted cancer therapies.